Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :27352049
Publication Date : 2016/06/29

Influence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated Proteins.


This study investigated the effects of matrix on the behaviors of 3D-cultured cells of two prostate cancer cell lines, LNCaP and DU145. Two biologically-derived matrices, Matrigel and Cultrex BME, and one synthetic matrix, the Alvetex scaffold, were used to culture the cells. The cell proliferation rate, cellular response to anti-cancer drugs, and expression levels of proteins associated with drug sensitivity/resistance were examined and compared amongst the 3D-cultured cells on the three matrices and 2D-cultured cells. The cellular responses upon treatment with two common anti-cancer drugs, Docetaxel and Rapamycin, were examined. The expressions of epidermal growth factor receptor (EGFR) and β-III tubulin in DU145 cells and p53 in LNCaP cells were examined. The results showed that the proliferation rates of cells cultured on the three matrices varied, especially between the synthetic matrix and the biologically-derived matrices. The drug responses and the expressions of drug sensitivity-associated proteins differed between cells on various matrices as well. Among the 3D cultures on the three matrices, increased expression of β-III tubulin in DU145 cells was correlated with increased resistance to Docetaxel, and decreased expression of EGFR in DU145 cells was correlated with increased sensitivity to Rapamycin. Increased expression of a p53 dimer in 3D-cultured LNCaP cells was correlated with increased resistance to Docetaxel. Collectively, the results showed that the matrix of 3D cell culture models strongly influences cellular behaviors, which highlights the imperative need to achieve standardization of 3D cell culture technology in order to be used in drug screening and cell biology studies.

Authors : Edmondson Rasheena , Adcock Audrey F , Yang Liju ,

Related products :

Catalog number Product name Quantity
orb60727 Flutamide Flutamide(Eulexin) is an oral nonsteroidal antiandrogen drug primarily used to treat prostate cancer. For research use only. 10 mg
SENSIVUESECONDARY Drug susceptibility (secondary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method. One Set
SENSIVUEPRIMARY Drug susceptibility (primary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method. One Set
orb61244 Erlotinib Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. For research use only. 100 mg
orb60291 Artemisinin Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria. For research use only. 200 mg
orb60556 Prednisone Prednisone(Adasone) is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant drug. For research use only. 25 mg
orb60448 Safinamide Mesylate Safinamide Mesylate is a candidate drug against Parkinson's disease with multiple methods of action. For research use only. 10 mg
orb84796 IL21 protein IL21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigenspecific responses of immune cells. The biological effec 10
orb82622 Rat IL21 protein IL21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigen-specific responses of immune cells. The biological 2
orb61248 GDC-0449 Vismodegib is an investigational drug for the treatment of various types of cancer. For research use only. 50 mg
orb61255 INCB018424 Ruxolitinib is a drug being investigated for the treatment of myeloproliferative diseases, plaque psoriasis, and various types of cancer. For research use only. 5 mg
orb61205 ABT-888 Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor.It inhibits both PARP1 and PARP2. For research use only. 10 mg
orb60240 Carboplatin This drug performed growth inhibitory activity in IGROV1 and OAW42 cells(IC50 of 25 and 30 mg_l,respectively). For research use only. 200 mg
orb61271 NVP-AUY922 NVP-AUY922 is an experimental drug candidate for the treatment of cancer. For research use only. 5 mg
orb61251 Gefitinib Gefitinib is a drug used in the treatment of certain types of cancer. For research use only. 100 mg
orb61351 Oxaliplatin Oxaliplatin is a a third-generation, diaminocyclohexane-containing platinum anti-cancer drug. For research use only. 500 mg
orb61241 Doxorubicin Doxorubicin is a drug used in cancer chemotherapy. For research use only. 100 mg
orb60355 Amonafide Amonafide is a drug used in the treatment of cancer. For research use only. 5 mg
orb61254 Imatinib (free base) Imatinib (originally STI571) is a drug used to treat certain types of cancer. For research use only. 100 mg
orb60741 Levamisole Hydrochloride Levamisole Hydrochloride(Ergamisol)is an antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by incr 10 mg
Z1322005 AnaPrep Cultured Cell DNA Extraction Kit (48) For extracting genomic DNA from up to 5x105 cultured cells 1 kit (48 extractions) Including all required plastic disposables
QDU Drug Abuse urine Drug Abuse 1000
orb61256 Lapatinib (free base) Lapatinib, used in the form of lapatinib ditosylate, (USAN) (Tykerb_Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. For research use only. 100 mg
EIAAB40264 Homo sapiens,Human,Metalloreductase STEAP2,PCANAP1,Prostate cancer-associated protein 1,Protein upregulated in metastatic prostate cancer,PUMPCn,Six-transmembrane epithelial antigen of prostate 2,SixT
orb61230 Canertinib Canertinib (CI-1033) is an experimental drug candidate for the treatment of cancer. It is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 500 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur